Clinical Trial Update: Buprenorphine/Raltegravir Pharmacokinetic Interaction Study [NA]

View source ↗

Summary

A pharmacokinetic interaction study evaluated the co-administration of buprenorphine and raltegravir in HIV-infected individuals, with results posted in 2012.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Isentress (Raltegravir)
• buprenorphine (buprenorphine)

Snippet

Sponsor: Yale University | Conditions: HIV Infection, HIV Infections | NA | Status: COMPLETED | Results posted: 2012-11-21